INSP | Inspire Medical Systems, Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	151.82 - 161.04
52 Week Range	123.00 - 257.40
Beta	0.97
Implied Volatility	65.26%
IV Rank	66.96%
Day's Volume	278,920
Average Volume	550,657
Shares Outstanding	29,759,700
Market Cap	4,740,125,016
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2018-05-03

Valuation
Profitability
Growth
Health
P/E Ratio	91.02
Forward P/E Ratio	-268.63
EPS	1.75
1YR Price Target	307.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,011
Country	USA
Website	INSP

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

INSP's peers: ALGN, BFLY, BIO, CLPT, DXCM, GMED, INMD, TMDX, NARI, PODD, SWAV, GKOS, TNDM, PEN, OM, NVCR, MASI, PHG, QDEL

*Chart delayed

Analyzing fundamentals for INSP we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is good and Health is passable. For more detailed analysis please see INSP Fundamentals page.

Watching at INSP technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INSP Technicals page.